可药物调控的尤文肉瘤治疗靶点？
A Druggable Rheostat for Ewing Sarcoma?
机构信息
Department of Orthopedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
出版信息
Clin Cancer Res. 2022 Oct 14;28(20):4360-4362. doi: 10.1158/1078-0432.CCR-22-1794.
Abstract
The posterior HOXD enhancer is an EWSR1::FLI1-dependent regulator of HOXD13 expression in Ewing sarcoma. HOXD13 expression promotes a mesenchymal cell state. Through antagonistic transcriptional programs, EWSR1::FLI1 and HOXD13 serve as master regulators of Ewing cell plasticity. Targeting Ewing cells as they exist in/transition between mesenchymal states is a priority. See related article by Apfelbaum et al., p. 4466.
摘要
后部 HOXD 增强子是 Ewing 肉瘤中 EWSR1::FLI1 依赖性 HOXD13 表达的调节剂。HOXD13 的表达促进了间充质细胞状态。通过拮抗转录程序，EWSR1::FLI1 和 HOXD13 作为 Ewing 细胞可塑性的主要调节剂。以 Ewing 细胞存在于/过渡到间充质状态的状态为靶点是当务之急。见 Apfelbaum 等人的相关文章，第 4466 页。
相似文献
1
A Druggable Rheostat for Ewing Sarcoma?可药物调控的尤文肉瘤治疗靶点？
Clin Cancer Res. 2022 Oct 14;28(20):4360-4362. doi: 10.1158/1078-0432.CCR-22-1794.
2
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma.EWS::FLI1 和 HOXD13 控制尤文肉瘤肿瘤细胞的可塑性。
Clin Cancer Res. 2022 Oct 14;28(20):4466-4478. doi: 10.1158/1078-0432.CCR-22-0384.
3
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma.EWS-FLI1 和 Menin 共同调控尤文肉瘤中 ATF4 活性。
Mol Cancer Res. 2021 Jul;19(7):1182-1195. doi: 10.1158/1541-7786.MCR-20-0679. Epub 2021 Mar 19.
4
EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.EWS-FLI1 通过与 Foxq1 合作在小鼠尤文肉瘤中调节转录程序。
Cancer Sci. 2018 Sep;109(9):2907-2918. doi: 10.1111/cas.13710. Epub 2018 Jul 18.
5
EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma.EWS/FLI 是尤文肉瘤代谢重编程的主要调控因子。
Mol Cancer Res. 2017 Nov;15(11):1517-1530. doi: 10.1158/1541-7786.MCR-17-0182. Epub 2017 Jul 18.
6
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation.EWS-FLI1 介导的增强子激活的拮抗作用导致尤文肉瘤中 ETV6 的依赖性。
Nat Cell Biol. 2023 Feb;25(2):298-308. doi: 10.1038/s41556-022-01060-1. Epub 2023 Jan 19.
7
Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.EWS-FLI1 融合蛋白的连接区在体外具有 Ewing 肉瘤的显性负效应。
BMC Cancer. 2012 Nov 12;12:513. doi: 10.1186/1471-2407-12-513.
8
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma.USP9X 抑制作用消除 EWS-FLI1 可抑制尤文肉瘤中癌细胞的生长。
Cancer Lett. 2023 Jan 1;552:215984. doi: 10.1016/j.canlet.2022.215984. Epub 2022 Oct 29.
9
Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.FOXO1 的抑制是 EWS-FLI1 在尤文肉瘤中生长调控抑制转录亚特征的原因。
Oncogene. 2014 Jul 24;33(30):3927-38. doi: 10.1038/onc.2013.361. Epub 2013 Sep 2.
10
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.EWS/FLI 介导的 3D 染色质重编程促进尤文肉瘤中改变的转录状态。
Nucleic Acids Res. 2022 Sep 23;50(17):9814-9837. doi: 10.1093/nar/gkac747.
本文引用的文献
1
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma.EWS::FLI1 和 HOXD13 控制尤文肉瘤肿瘤细胞的可塑性。
Clin Cancer Res. 2022 Oct 14;28(20):4466-4478. doi: 10.1158/1078-0432.CCR-22-0384.
2
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.一个癌基因，多种脆弱性：尤因肉瘤的EWS/FLI靶向疗法
J Bone Oncol. 2021 Dec 1;31:100404. doi: 10.1016/j.jbo.2021.100404. eCollection 2021 Dec.
3
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression.CD8 T 细胞来源的细胞外囊泡通过 CD73 介导的腺苷产生构成了免疫抑制的固有机制。
Nat Commun. 2021 Oct 8;12(1):5911. doi: 10.1038/s41467-021-26134-w.
4
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.TRIM8 通过调节 EWS/FLI 癌蛋白促进尤文肉瘤的存活。
Cancer Cell. 2021 Sep 13;39(9):1262-1278.e7. doi: 10.1016/j.ccell.2021.07.003. Epub 2021 Jul 29.
5
CD73: an emerging checkpoint for cancer immunotherapy.CD73：癌症免疫治疗的新兴检查点。
Immunotherapy. 2019 Aug;11(11):983-997. doi: 10.2217/imt-2018-0200. Epub 2019 Jun 21.
6
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells.EWSR1-FLI1活性的细胞间异质性决定了尤因肉瘤细胞的增殖/迁移选择。
Oncogene. 2017 Jun 22;36(25):3505-3514. doi: 10.1038/onc.2016.498. Epub 2017 Jan 30.
7
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.尤因肉瘤细胞中Wnt/β-连环蛋白的激活拮抗EWS/ETS功能，并促进表型转变为更具转移性的细胞状态。
Cancer Res. 2016 Sep 1;76(17):5040-53. doi: 10.1158/0008-5472.CAN-15-3422. Epub 2016 Jun 30.
8
The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma.EWS/FLI致癌基因驱动尤因肉瘤细胞形态、黏附和迁移的变化。
Genes Cancer. 2012 Feb;3(2):102-16. doi: 10.1177/1947601912457024.
9
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.编码转化生长因子-β II型受体的基因的抑制是EWS-FLI1癌蛋白的主要作用靶点。
Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854.
Zotero 插件